Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150012/S191

ESSENTIO MRI (Model L131); PROPONENT MRI (Model L231); ACCOLADE MRI (Model L331); ESSENTIO MRI (Models L110, L111); PRO

Boston Scientific · Decision date Oct 3, 2026

MEDTECHLEDGER EXPLANATIONP150012/S191

What did the FDA decide?

The FDA record P150012/S191 lists Boston Scientific as applicant for a 30-Day Notice supplement to PMA P150012, decided OK30 on 2026-10-03. The reported statement describes two manufacturing-related actions: implementing an additional acceptance activity for Accolade SL batteries and changing a specification for an existing Accolade EL battery specification. The device category is implantable pulse generator, pacemaker (non-CRT), product code LWP.

The action concerns battery acceptance and specification items, not a new approval of the whole system. The record does not identify which acceptance activity was added, what the revised EL specification is, or what validation data supported either change, so those details remain absent and the statement's purpose is not evidence of safety or clinical effectiveness.

FDA approval order statement

to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 3, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150012/S191
Regulatory pathway
PMA supplement
Product code
LWP
Decision code
OK30
Decision date
Oct 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable pulse generator, pacemaker (non-CRT).

Product code
LWP
FDA device class
3

For the original device and its historical approval scope, see PMA P150012. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150012 · Original PMA

    IMAGEREADY MR CONDITIONAL PACING SYSTEM AND INGEVITY PACE/SENSE LEAD

  2. P150012/S191 received

    Application receipt date recorded by FDA.

  3. P150012/S191 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P150012. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150012

Product / regulatory recordCompanyPathwayDecision dateSource
Boston ScientificPMA approvalApr 25, 2016FDA

Explore the linked device profile

Other records with product code LWP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific

Headquarters
Not reported
FDA applicant address
4100 Hamline Ave. N, St Paul, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records